Navigating UK and EU Supplement Regulations: Compliance Standards for Brand Owners
An editorial overview of the regulatory frameworks governing food supplements in the UK and EU, detailing statutory requirements for ingredient safety, health claim substantiation, and manufacturing quality standards.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Ensuring regulatory compliance across the United Kingdom and the European Union remains a primary operational requirement for food supplement brand owners, formulators, and contract manufacturing organisations (CMOs). Within this sector, finished products presented as food supplements must satisfy specific statutory criteria governing compositional safety, labelling accuracy, and commercial claims.
Following the UK's departure from the European Union, regulatory oversight separated into distinct administrative jurisdictions. In Great Britain (England, Scotland, and Wales), food supplements are governed domestically under assimilated EU law alongside national statutory instruments, enforced by local authorities and the Food Standards Agency (FSA). Northern Ireland continues to apply EU harmonised rules under current protocol arrangements. Within the EU single market, compliance remains anchored in Directive 2002/46/EC and the risk-assessment remit of the European Food Safety Authority (EFSA). While fundamental technical standards broadly align, commercial operators must navigate independent administrative pathways and territory-specific national provisions.
## Permitted Ingredients and Novel Foods Authorisation
A critical milestone in formulation development is establishing whether active botanicals, synthetic compounds, or mineral sources are legally permitted in food supplements. Under both UK and EU frameworks, vitamin and mineral substances must be drawn from statutory positive lists, which define permitted chemical forms, bioavailable sources, and purity criteria.
For substances without an established history of significant human consumption within the EU or UK prior to 15 May 1997, the Novel Food regime applies. In the EU, Regulation (EU) 2015/2283 requires a pre-market safety evaluation by EFSA and formal authorisation from the European Commission. In Great Britain, the FSA and Food Standards Scotland (FSS) administer an independent regulated products application pathway. Formulators must confirm the regulatory status of new compounds via the relevant national catalogue or through formal consultation under Article 4 procedures. Commercial distribution of unauthorised novel ingredients exposes operators to product withdrawals, inventory seizures, and statutory enforcement.
## Health Claims and Statutory Labelling Requirements
Commercial communications and packaging copy are governed by Regulation (EC) No 1924/2006, retained in domestic UK legislation. General statements implying non-specific health benefits are legally permissible only when accompanied by a specific, authorised claim listed on the applicable official register.
To maintain compliance, brand owners must observe several regulatory parameters:
- **Register alignment:** Utilising authorised claims listed on the Great Britain nutrition and health claims register or the EU equivalent, depending on the target jurisdiction.
- **Conditions of use:** Formulating finished goods to meet specific qualifying thresholds, including minimum quantities of the active nutrient per daily recommended dose (typically a significant amount, defined as 15% of the Nutrient Reference Value).
- **Medicinal claims exclusion:** Food supplements are legally classified as foodstuffs; commercial copy cannot state or imply properties of preventing, treating, or curing human disease (Regulation (EU) No 1169/2011).
- **Mandatory disclosures:** Providing clear labelling declarations, including net quantity, minimum durability dates, batch identification, recommended daily intake instructions, and statutory warnings advising consumers not to exceed the stated dose.
## Quality Assurance and Good Manufacturing Practice
Beyond formulation and pack copy, operational due diligence requires verifiable quality-assurance systems across the supply chain. Food supplements fall within general food hygiene legislation—including Regulation (EC) No 852/2004 and the UK Food Safety Act 1990—mandating documented Hazard Analysis Critical Control Point (HACCP) principles.
To satisfy regulatory audits and customer diligence, brand owners routinely partner with contract manufacturers certified against established food safety and Good Manufacturing Practice (GMP) standards, such as BRCGS, FSSC 22000, or ISO 22000. Analytical verification protocols must confirm batch compliance against statutory maximum limits for heavy metals (lead, cadmium, mercury, and inorganic arsenic), microbiological pathogens, pesticide residues, and extraction solvents. Furthermore, stability testing is required to verify that active nutrient degradation does not fall below declared label values during the product's defined shelf life.